Ask AI
ProCE Banner Activity

Latest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma

Podcast Episodes

Listen to Dr Brad Kahl and Dr Noopur Raje discuss the latest advances in CAR T-cell therapy for lymphomas and multiple myeloma including the latest evidence from long-term clinical trial follow-up and real-world data, plus new data with CAR T-cell therapies in new lymphoma settings and novel CAR T-cell therapies currently under development for multiple myeloma.

Released: September 03, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Disclosure

Primary Author

Brad Kahl, MD: consultant/advisor/speaker: AbbVie, ADCT, AstraZeneca, BeiGene, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Lilly, Merck, Pfizer, Roche.

Noopur Raje, MD: consultant/advisor/speaker: AstraZeneca, Bristol Myers Squibb, Caribou Biosciences, GlaxoSmithKline, Johnson & Johnson, Moderna, Pfizer, Regeneron, Sanofi.